D323-0313 Screening compound: 2-[1-(4-bromobenzoyl)piperidin-4-yl]-1,3-benzoxazole

D323-0313 Screening compound: 2-[1-(4-bromobenzoyl)piperidin-4-yl]-1,3-benzoxazole
D323-0313 Screening compound: 2-[1-(4-bromobenzoyl)piperidin-4-yl]-1,3-benzoxazole alternative view

Chemical Structure Depiction of ChemDiv screening compound D323-0313
2-[1-(4-bromobenzoyl)piperidin-4-yl]-1,3-benzoxazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D323-0313

Molecular Formula

C19H17BrN2O2 (C19 H17 BrN2 O2)

Compound Name

2-[1-(4-bromobenzoyl)piperidin-4-yl]-1,3-benzoxazole

IUPAC name

2-[1-(4-bromobenzoyl)piperidin-4-yl]-13-benzoxazole

SMILES

O=C(c(cc1)ccc1Br)N(CC1)CCC1c1nc(cccc2)c2o1

InChI

InChI=1S/C19H17BrN2O2/c20-15-7-5-14(6-8-15)19(23)22-11-9-13(10-12-22)18-21-16-3-1-2-4-17(16)24-18/h1-8,13H,9-12H2

InChI Key

DWDQJSCCMNEFJH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01275741

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

385.26

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.527

Distribution Coefficient, logD

4.527

Water Solubility, LogSw

-4.46

Polar Surface Area

33.697

Acid Dissociation Constant (pKa)

26.01

Base Dissociation Constant (pKb)

-1.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

D323-0313 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

C-Met Library (15277 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D323-0313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D323-0313?
Check Price and Availability of D323-0313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D323-0313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D323-0313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D323-0313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D323-0313 available by request